PROVIDER PROFILE · NPI 1588722680
Iris GinMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,566
Unique beneficiaries
—
Total services
16,803
Distinct HCPCS
25
Medicare payment
$1.1M
Peer benchmark
Total Medicare services vs. 1,546 Dermatology providers in CA — top quintile (cohort median 2,504).
PRESCRIBING · PART D · 2024
Total Rx claims
221
Beneficiaries
—
Total drug cost
$32K
Distinct drugs
10
Brand share
46.6%
Top prescribed drugs
Betamethasone/Propylene Glyc48 claims
Fluorouracil30 claims
Cephalexin29 claims
Ciclopirox Olamine23 claims
Mupirocin20 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
13.0
Cost
79.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$5K
Payment records
156
By payment type
Food and Beverage$5K
Education$35
Top paying entities
Food and Beverage$5K
Education$35
REFERRAL NETWORK
Where Iris Gin's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Ucsf Dermatopathology Service Clinical Laboratory · San Francisco, CA | 71 | 112 |
| NPI 1447682380 | 15 | 22 |
| GOOD SAMARITAN HOSPITAL, L.P. | 11 | 13 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE